Cargando…
Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
In this review, we compared recommendations from the Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) to other global treatment guidelines for depression. Six global treatment guidelines were reviewed; among the six, 4 were evidence-based guidelines, 1 was an expert co...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565074/ https://www.ncbi.nlm.nih.gov/pubmed/28783928 http://dx.doi.org/10.9758/cpn.2017.15.3.199 |
_version_ | 1783258358790225920 |
---|---|
author | Wang, Hee Ryung Bahk, Won-Myong Seo, Jeong Seok Woo, Young Sup Park, Young-Min Jeong, Jong-Hyun Kim, Won Shim, Se-Hoon Lee, Jung Goo Jon, Duk-In Min, Kyung Joon |
author_facet | Wang, Hee Ryung Bahk, Won-Myong Seo, Jeong Seok Woo, Young Sup Park, Young-Min Jeong, Jong-Hyun Kim, Won Shim, Se-Hoon Lee, Jung Goo Jon, Duk-In Min, Kyung Joon |
author_sort | Wang, Hee Ryung |
collection | PubMed |
description | In this review, we compared recommendations from the Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) to other global treatment guidelines for depression. Six global treatment guidelines were reviewed; among the six, 4 were evidence-based guidelines, 1 was an expert consensus-based guideline, and 1 was an amalgamation of both evidence and expert consensus-based recommendations. The recommendations in the KMAP-DD 2017 were generally similar to those in other global treatment guidelines, although there were some differences between the guidelines. The KMAP-DD 2017 appeared to reflect current changes in the psychopharmacology of depression quite well, like other recently published evidence-based guidelines. As an expert consensus-based guideline, the KMAP-DD 2017 had some limitations. However, considering there are situations in which clinical evidence cannot be drawn from planned clinical trials, the KMAP-DD 2017 may be helpful for Korean psychiatrists making decisions in the clinical settings by complementing previously published evidence-based guidelines. |
format | Online Article Text |
id | pubmed-5565074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Korean College of Neuropsychopharmacology |
record_format | MEDLINE/PubMed |
spelling | pubmed-55650742017-08-23 Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines Wang, Hee Ryung Bahk, Won-Myong Seo, Jeong Seok Woo, Young Sup Park, Young-Min Jeong, Jong-Hyun Kim, Won Shim, Se-Hoon Lee, Jung Goo Jon, Duk-In Min, Kyung Joon Clin Psychopharmacol Neurosci Review In this review, we compared recommendations from the Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) to other global treatment guidelines for depression. Six global treatment guidelines were reviewed; among the six, 4 were evidence-based guidelines, 1 was an expert consensus-based guideline, and 1 was an amalgamation of both evidence and expert consensus-based recommendations. The recommendations in the KMAP-DD 2017 were generally similar to those in other global treatment guidelines, although there were some differences between the guidelines. The KMAP-DD 2017 appeared to reflect current changes in the psychopharmacology of depression quite well, like other recently published evidence-based guidelines. As an expert consensus-based guideline, the KMAP-DD 2017 had some limitations. However, considering there are situations in which clinical evidence cannot be drawn from planned clinical trials, the KMAP-DD 2017 may be helpful for Korean psychiatrists making decisions in the clinical settings by complementing previously published evidence-based guidelines. Korean College of Neuropsychopharmacology 2017-08 2017-08-31 /pmc/articles/PMC5565074/ /pubmed/28783928 http://dx.doi.org/10.9758/cpn.2017.15.3.199 Text en Copyright © 2017, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Wang, Hee Ryung Bahk, Won-Myong Seo, Jeong Seok Woo, Young Sup Park, Young-Min Jeong, Jong-Hyun Kim, Won Shim, Se-Hoon Lee, Jung Goo Jon, Duk-In Min, Kyung Joon Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines |
title | Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines |
title_full | Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines |
title_fullStr | Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines |
title_full_unstemmed | Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines |
title_short | Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines |
title_sort | korean medication algorithm for depressive disorder: comparisons with other treatment guidelines |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565074/ https://www.ncbi.nlm.nih.gov/pubmed/28783928 http://dx.doi.org/10.9758/cpn.2017.15.3.199 |
work_keys_str_mv | AT wangheeryung koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT bahkwonmyong koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT seojeongseok koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT wooyoungsup koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT parkyoungmin koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT jeongjonghyun koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT kimwon koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT shimsehoon koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT leejunggoo koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT jondukin koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines AT minkyungjoon koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines |